Henry Schein (HSIC) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Henry Schein ( HSIC) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Henry Schein as such a stock due to the following factors:

  • HSIC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $45.2 million.
  • HSIC has traded 120,244 shares today.
  • HSIC is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HSIC with the Ticky from Trade-Ideas. See the FREE profile for HSIC NOW at Trade-Ideas

More details on HSIC:

Henry Schein, Inc. provides health care products and services worldwide. It operates in two segments, Health Care Distribution; and Technology and Value-Added Services. HSIC has a PE ratio of 26. Currently there are 6 analysts that rate Henry Schein a buy, 1 analyst rates it a sell, and 8 rate it a hold.

The average volume for Henry Schein has been 460,400 shares per day over the past 30 days. Henry Schein has a market cap of $11.9 billion and is part of the services sector and wholesale industry. The stock has a beta of 0.99 and a short float of 2.5% with 6.58 days to cover. Shares are up 4.5% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Henry Schein: Cramer's Top Takeaways

Stocks Are Fighting Back: Cramer's 'Mad Money' Recap (Wednesday 8/9/17)

Analysts' Actions -- Lululemon, L Brands, Masco, Under Armour and More

End of Health-Care Bill Could Be a Win for Markets: Cramer's 'Mad Money' Recap (Friday 3/24/17)

Walmart, Nike, Henry Schein Set to Shine